Kratom Products Move Into the Mainstream in 2026

Once a fringe botanical, kratom is now firmly on the radar of wellness consumers looking for alternatives to conventional painkillers and stimulants. Mitragyna speciosa, the Southeast Asian tree that kratom comes from, contains alkaloids such as mitragynine and 7-hydroxymitragynine, which can produce both stimulant and analgesic, opioid-like effects depending on dose. In 2026, products range from pre-measured liquids and capsules to teas, smoking formats and blended powders, all designed to offer controlled dosing and more palatable ways to experiment with the plant. Advocates point to emerging research suggesting kratom may carry lower addiction potential than traditional opioids and could help some people taper off them, though more rigorous studies are needed. Consumers are urged to check local laws before buying, as several U.S. states and municipalities still ban the herb. For the original overview, see Forbes’ guide to notable kratom products.